Open AccessGraft-versus-host disease is the major determinant of humoral responses to the AS03-adjuvanted influenza A/09/H1N1 vaccine in allogeneic hematopoietic stem cell transplant recipients
Author(s) -
Bilal Mohty,
Miquel Jordi Bel,
Marija Vukicevic,
Mariangy,
Emmanuel Levrat,
S. Meier,
Stéphane Grillet,
Christophe Combescure,
Laurent Kaiser,
Yves Chalandon,
Jakob Passweg,
ClaireAnne Siegrist,
Eddy Roosnek
Publication year - 2011
Publication title -
haematologica
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.782
H-Index - 142
eISSN - 1592-8721
pISSN - 0390-6078
DOI - 10.3324/haematol.2011.040386
Subject(s) - medicine , vaccination , immunology , seroconversion , hematopoietic stem cell transplantation , graft versus host disease , antibody , influenza vaccine , antibody titer , transplantation , titer
Responses to influenza vaccines are poorly characterized in immunocompromised patients. The goal of this study was to assess the efficacy of the AS03-adjuvanted influenza H1N1/A/09 vaccine in allogeneic hematopoietic stem cell transplant recipients.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom